scholarly journals Growth suppression activity of bradykinin antagonists in glioma cells

2014 ◽  
Vol 30 (1) ◽  
pp. 77-79 ◽  
Author(s):  
S. S. Avdieiev ◽  
L. Gera ◽  
R. Hodges ◽  
Y. S. Vassetzky ◽  
V. M. Kavsan
1997 ◽  
Vol 94 (23) ◽  
pp. 12479-12484 ◽  
Author(s):  
F. B. Furnari ◽  
H. Lin ◽  
H.- J. S. Huang ◽  
W. K. Cavenee

1994 ◽  
Vol 81 (3) ◽  
pp. 402-410 ◽  
Author(s):  
Satoshi Tanaka ◽  
Tadashi Nagashima ◽  
Shinya Manaka ◽  
Tomokatsu Hori ◽  
Shigeru Yasumoto

✓ The effect of recombinant human interleukin-1 (rHuIL-1) derivatives on human glioma cell lines was examined in vitro. Five glioma cell lines, U-251 MG, U-373 MG, U-87 MG, A-172, and T98G, were incubated in medium containing 1% fetal calf serum and various concentrations of different types of rHuIL-1: OCT-43 (rHuIL-1β), OCT-7000 (rHuIL-1α), and OCT-8000 (rHuIL-1α). The high-affinity IL-1 receptors were expressed in the U-251 MG and U-373 MG cell lines, and rHuIL-1 was found to suppress cell growth and to induce morphological differentiation of these cell lines. Growth inhibition occurred in a dose-dependent manner in concentrations or rHuIL-1 ranging between 1 and 100 ng/ml. Interestingly, rHuIL-1 induced a transient growth of glioma cells shortly after administration, then suppressed cell growth with accompanying elongation of cytoplasmic processes. This unique process of transient growth stimulation followed by growth suppression was parallel to the efficacy of bromodeoxyuridine uptake in the rHuIL-1-treated cells. Concomitantly, accumulation of glial fibrillary acidic protein and cyclic adenosine monophosphate contents was observed in four glioma cell lines. Continuous rHuIL-1 treatment for longer than 30 days elicited irreversible astrocytic terminal differentiation. These results indicate that IL-1 is an effector on the growth regulation of glioma cells, resulting in astrocytic differentiation in vitro.


2016 ◽  
Vol Volume 9 ◽  
pp. 5195-5202 ◽  
Author(s):  
Zhuxin Wei ◽  
Yu Zhang ◽  
Suning Huang ◽  
Yuhua Leng ◽  
Xin Chen ◽  
...  

2016 ◽  
Vol 5 (3) ◽  
pp. 486-499 ◽  
Author(s):  
Yusuke Nitta ◽  
Saki Shimizu ◽  
Yukiko Shishido‐Hara ◽  
Kaori Suzuki ◽  
Yoshiaki Shiokawa ◽  
...  

Neoplasma ◽  
2015 ◽  
Vol 62 (04) ◽  
pp. 574-581 ◽  
Author(s):  
Y. RUAN ◽  
S. HUANG ◽  
D. HE ◽  
R. GOPAUL ◽  
Z. LI ◽  
...  

Gene Therapy ◽  
2004 ◽  
Vol 11 (15) ◽  
pp. 1195-1204 ◽  
Author(s):  
R Inoue ◽  
K A Moghaddam ◽  
M Ranasinghe ◽  
Y Saeki ◽  
E A Chiocca ◽  
...  

2020 ◽  
Vol 174 ◽  
pp. 113823
Author(s):  
Dewi Safitri ◽  
Matthew Harris ◽  
Harriet Potter ◽  
Ho Yan Yeung ◽  
Ian Winfield ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document